Quality of reporting of bioequivalence trials comparing generic to brand name drugs: a methodological systematic review.
BACKGROUND: Generic drugs are used by millions of patients for economic reasons, so their evaluation must be highly transparent. OBJECTIVE: To assess the quality of reporting of bioequivalence trials comparing generic to brand-name drugs. METHODOLOGY/PRINCIPAL FINDINGS: PubMed was searched for repor...
Main Authors: | Amélie van der Meersch, Agnès Dechartres, Philippe Ravaud |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3157430?pdf=render |
Similar Items
-
Generic Drug Product Development Bioequivalence Issues
by: Iain J. McGilveray
Published: (2008-08-01) -
The concept of: Generic drugs and patented drugs Vs brand name drugs and non-proprietary (generic) name drugs.
by: Karan eThakkar, et al.
Published: (2013-09-01) -
Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations
by: Zhao XY, et al.
Published: (2013-11-01) -
Evaluating the bioequivalence of levetiracetam brand and generic oral tablets available in the Saudi market in vivo
by: Danah ALRabeeah, et al.
Published: (2023-10-01) -
Planning and Evaluation of Bioequivalence Studies of Telmisartan Generic Drug Products
by: A. L. Khokhlov, et al.
Published: (2019-09-01)